Volpara delivers more explosive growth in the first half of FY 2020

The Volpara Health Technologies Ltd (ASX:VHT) share price could be on the move today after the release of its half year result…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volpara Health Technologies Ltd (ASX: VHT) share price will be on watch today following the release of its half year results.

How did Volpara perform in the first half?

For the six months ended September 30, Volpara reported total revenue of NZ$6.84 million. This was a 197% increase on the prior corresponding period. Software as a service revenue from customers lifted 63% to NZ$2.93 million.

The company's annual recurring revenue (ARR) also grew strongly during the half. At the end of the period its ARR reached NZ$15.7 million, up 227% on the NZ$4.8 million achieved a year earlier.

This has been driven by increasing demand for its software and the successful acquisition of Seattle-based MRS Systems for US$14.6 million.

Another positive was the percentage of women in the United States having a group product applied on their images and data. This has increased to 25.8% from 5.6% a year earlier.

Volpara's CEO, Dr Ralph Highnam, appears very pleased with the first half performance.

He said: "This past half-year has positioned us well financially for our next stage of growth. We have funds from a successful capital raise, a more solid cash position, stronger revenue streams and a full suite of breast-screening products."

"MRS Systems has been successfully integrated into Volpara, and we are already seeing our hard work translate into increased customer numbers. We can now optimise the benefits that MRS has brought to Volpara, which includes a bolstered data base. We come to the table with a stronger offering to help our patients beat cancer," he added.

Outlook.

Management advised that Volpara is on track to meet its mid-range forecast for ARR of NZ$17.1 million in FY 2020.  

It also remains on track to achieve its forecast of 27% of US women having a group product applied on their images and data.

Volpara isn't the only New Zealand-based technology share reporting its half year results today. Leading travel and expense technology solution provider Serko Ltd (ASX: SKO) also released its half year result and reported strong operating revenue growth.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Serko Ltd and VOLPARA FPO NZ. The Motley Fool Australia has recommended Serko Ltd and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »